Published: 18 July 2024
Author(s): Mehmet Kanbay, Mustafa Guldan, Lasin Ozbek, Sidar Copur, Andreea Simona Covic, Adrian Covic
Section: Review Article

Metabolic syndrome (MS) or Cardiovascular-Kidney-Metabolic (CKM) syndrome, the global epidemic with prevalence increasing from 25.3 % in 1988–1994 to 34.2 % in 2007–2012 in the adult population of the United States, has been defined according to the American Heart Association criteria as a systemic disorder characterized by interactions in-between multiple metabolic risk factors including cardiovascular risk factors such as hypertension, hyperlipidemia and hyperglycemia, and chronic kidney disease that has the potential to lead into high rates of major adverse cardiovascular events [1].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness